rdf:type |
|
lifeskim:mentions |
umls-concept:C0035553,
umls-concept:C0073337,
umls-concept:C0205250,
umls-concept:C0205314,
umls-concept:C0205369,
umls-concept:C0679622,
umls-concept:C0753627,
umls-concept:C1419748,
umls-concept:C1705582,
umls-concept:C1836606,
umls-concept:C1880022,
umls-concept:C1999216
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-9-29
|
pubmed:abstractText |
S6K1 (p70 ribosomal S6 kinase 1) is activated by insulin and growth factors via the PI3K (phosphoinositide 3-kinase) and mTOR (mammalian target of rapamycin) signalling pathways. S6K1 regulates numerous processes, such as protein synthesis, growth, proliferation and longevity, and its inhibition has been proposed as a strategy for the treatment of cancer and insulin resistance. In the present paper we describe a novel cell-permeable inhibitor of S6K1, PF-4708671, which specifically inhibits the S6K1 isoform with a Ki of 20 nM and IC50 of 160 nM. PF-4708671 prevents the S6K1-mediated phosphorylation of S6 protein in response to IGF-1 (insulin-like growth factor 1), while having no effect upon the PMA-induced phosphorylation of substrates of the highly related RSK (p90 ribosomal S6 kinase) and MSK (mitogen- and stress-activated kinase) kinases. PF-4708671 was also found to induce phosphorylation of the T-loop and hydrophobic motif of S6K1, an effect that is dependent upon mTORC1 (mTOR complex 1). PF-4708671 is the first S6K1-specific inhibitor to be reported and will be a useful tool for delineating S6K1-specific roles downstream of mTOR.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphothreonine,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 70-kDa,
http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 90-kDa,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/mTORC1 complex, human,
http://linkedlifedata.com/resource/pubmed/chemical/mitogen and stress-activated...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1470-8728
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
431
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
245-55
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20704563-Cell Line,
pubmed-meshheading:20704563-Humans,
pubmed-meshheading:20704563-Imidazoles,
pubmed-meshheading:20704563-Phosphorylation,
pubmed-meshheading:20704563-Phosphothreonine,
pubmed-meshheading:20704563-Piperazines,
pubmed-meshheading:20704563-Protein Kinase Inhibitors,
pubmed-meshheading:20704563-Proteins,
pubmed-meshheading:20704563-Ribosomal Protein S6 Kinases, 70-kDa,
pubmed-meshheading:20704563-Ribosomal Protein S6 Kinases, 90-kDa,
pubmed-meshheading:20704563-Substrate Specificity,
pubmed-meshheading:20704563-Transcription Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
|
pubmed:affiliation |
MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee, Scotland, U.K. l.r.pearce@dundee.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|